EWTX – edgewise therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Why Edgewise Therapeutics Stock Topped the Market on Tuesday [Yahoo! Finance]
Edgewise Therapeutics (EWTX) had its price target raised by JPMorgan Chase & Co. from $34.00 to $45.00. They now have an "overweight" rating on the stock.
Edgewise Therapeutics (EWTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $32.00 price target on the stock.
Why Edgewise Therapeutics (EWTX) Is Up 6.4% After Long-Term Sevasemten Becker Data - And What's Next [Yahoo! Finance]
Edgewise Therapeutics Talks Phase III Becker Readout, EDG-7500 HCM Data Due in Q2 at Conference [Yahoo! Finance]
Form 144 Edgewise Therapeutics, Filed by: Donovan Joanne M.
Form 10-K Edgewise Therapeutics, For: Dec 31
Form 8-K Edgewise Therapeutics, For: Feb 26
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Form 4 Edgewise Therapeutics, For: Jan 21 Filed by: Edris Badreddin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.